Tissue Repair and Regeneration are complex processes involving the restoration of damaged or injured tissues to their normal structure and function. These processes are essential for maintaining tissue homeostasis, healing wounds, and restoring tissue function after injury or disease. Tissue repair begins immediately after injury with the formation of a blood clot to stop bleeding and create a temporary scaffold for tissue repair. Inflammation follows, characterized by the infiltration of immune cells to remove debris, pathogens, and damaged cells from the injury site. During the proliferative phase of tissue repair, fibroblasts and endothelial cells migrate to the injury site and proliferate, leading to the formation of granulation tissue. Fibroblasts deposit collagen and other extracellular matrix (ECM) components, while endothelial cells form new blood vessels to supply oxygen and nutrients to the healing tissue. In the remodelling phase, which can last for months to years, the newly formed tissue undergoes structural reorganization and maturation. Collagen fibres are rearranged, ECM components are degraded and replaced, and blood vessels regress as the tissue matures and gains strength. Regenerative processes aim to restore tissue function by replacing damaged or lost cells through cell proliferation, differentiation, and migration. Stem cells, progenitor cells, and resident tissue cells contribute to tissue regeneration by replenishing lost cell populations and rebuilding tissue architecture.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States